Xuehua Li, Yingkui Zhong, Chenglang Yuan, Jinjiang Lin, Xiaodi Shen, Minyi Guo, Baolan Lu, Jixin Meng, Yangdi Wang, Naiwen Zhang, Zixin Luo, Guimeng Hu, Ren Mao, Minhu Chen, Canhui Sun, Ziping Li, Qing-hua Cao, Baili Chen, Zhihui Chen, Bingsheng Huang, Shi-Ting Feng. Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic-clinical model. Int. J. Intell. Syst., 37(12):11853-11870, December 2022. [doi]
Abstract is missing.